These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prospects for using bacteriocins for the prevention and therapy of infections]. Blinova LP Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):10-4. PubMed ID: 6377774 [No Abstract] [Full Text] [Related]
4. [Function and structure of bacteriocins and rapidosomes]. Gariaev PP Usp Sovrem Biol; 1970; 70(2):166-81. PubMed ID: 5497762 [No Abstract] [Full Text] [Related]
5. Three recently acknowledged Escherichia species strikingly differ in the incidence of bacteriocinogenic and lysogenic strains. Smarda J; Smajs D; Lhotová H J Basic Microbiol; 2002; 42(6):429-33. PubMed ID: 12442305 [TBL] [Abstract][Full Text] [Related]
6. Recent data on the molecular biology of bacteriocins. Israil AM Arch Roum Pathol Exp Microbiol; 1984; 43(1):5-30. PubMed ID: 6397172 [No Abstract] [Full Text] [Related]
7. Bacteriocins and antagonism: the killing fields. Spriggs DR J Infect Dis; 1986 Apr; 153(4):809-10. PubMed ID: 3950455 [No Abstract] [Full Text] [Related]
8. Colicinogeny and related phenomena. Hardy KG Bacteriol Rev; 1975 Dec; 39(4):464-515. PubMed ID: 1108869 [No Abstract] [Full Text] [Related]
9. Production of antimicrobial substances, by hospital bacteria, active against other micro-organisms. Padilla C; Brevis P; Lobos O; Hubert E; Zamorano A J Hosp Infect; 2001 Sep; 49(1):43-7. PubMed ID: 11516185 [TBL] [Abstract][Full Text] [Related]
10. [The use of sporulating bacteria in treating patients with dysbacteriosis]. Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782 [TBL] [Abstract][Full Text] [Related]
11. Antineoplastic properties of bacteriocins: revisiting potential active agents. Cornut G; Fortin C; Soulières D Am J Clin Oncol; 2008 Aug; 31(4):399-404. PubMed ID: 18846002 [TBL] [Abstract][Full Text] [Related]
14. [Bacteriocinogenic study of Bac. anthracis in vivo]. Shuliak FS Veterinariia; 1979 Aug; (8):37. PubMed ID: 113925 [No Abstract] [Full Text] [Related]
15. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Cheikhyoussef A; Pogori N; Chen W; Zhang H Int J Food Microbiol; 2008 Jul; 125(3):215-22. PubMed ID: 18514343 [TBL] [Abstract][Full Text] [Related]
16. Modular structure of microcin H47 and colicin V. Azpiroz MF; Laviña M Antimicrob Agents Chemother; 2007 Jul; 51(7):2412-9. PubMed ID: 17452478 [TBL] [Abstract][Full Text] [Related]
17. [Use of a living culture of bacteriocinogenic strains of Streptococcus viridans (Streptobacterin) for the treatment of chronic tonsillitis]. Vershigora AE; Kondratsova TP; Feĭgin NP Zh Ushn Nos Gorl Bolezn; 1975; (2):32-4. PubMed ID: 1181767 [No Abstract] [Full Text] [Related]
18. [Epidemiologic bacterial markers: the basis of a study of nosocomial and community infections]. Boukadida J Tunis Med; 1995 Jan; 73(1):3-8. PubMed ID: 9506118 [No Abstract] [Full Text] [Related]
19. Bacteriocin-based strategies for food biopreservation. Gálvez A; Abriouel H; López RL; Ben Omar N Int J Food Microbiol; 2007 Nov; 120(1-2):51-70. PubMed ID: 17614151 [TBL] [Abstract][Full Text] [Related]